Next Article in Journal
Fragilides K and L, New Briaranes from the Gorgonian Coral Junceella fragilis
Next Article in Special Issue
Cosmetics Preservation: A Review on Present Strategies
Previous Article in Journal
In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones
Previous Article in Special Issue
Pentacyclic Triterpenes from Cecropia telenitida Can Function as Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
Open AccessArticle

(−)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats

1
School of Health and Biomedical Science, RMIT University, Bundoora, VIC 3083, Australia
2
School of Health, Medical and Applied Sciences, CQUniversity Australia, Rockhampton, QLD 4071, Australia
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(7), 1511; https://doi.org/10.3390/molecules23071511
Received: 7 May 2018 / Revised: 18 June 2018 / Accepted: 18 June 2018 / Published: 22 June 2018
(This article belongs to the Collection Bioactive Compounds)
(−)-Epicatechin (E) is a flavanol found in green tea and cocoa and has been shown to attenuate tumour necrosis factor alpha (TNF-α)-mediated inflammation, improve nitric oxide levels, promote endothelial nitric oxide synthase (eNOS) activation and inhibit NADPH oxidase. This study investigated the effect of 28 days of low epicatechin dosing (1 mg/kg/day) on the cardiovascular function of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Wistar rats (n = 120, 8 weeks of age) underwent uninephrectomy and were randomised into four groups (uninephrectomy (UNX), UNX + E, DOCA, DOCA + E). DOCA and DOCA + E rats received 1% NaCl drinking water along with subcutaneous injections of 25 mg deoxycorticosterone-acetate (in 0.4 mL of dimethylformamide) every fourth day. UNX + E and DOCA + E rats received 1 mg/kg/day of epicatechin by oral gavage. Single-cell micro-electrode electrophysiology, Langendorff isolated-heart assessment and isolated aorta and mesenteric organ baths were used to assess cardiovascular parameters. Serum malondialdehyde concentration was used as a marker of oxidative stress. Myocardial stiffness was increased and left ventricular compliance significantly diminished in the DOCA control group, and these changes were attenuated by epicatechin treatment (p < 0.05). Additionally, the DOCA + E rats showed significantly reduced blood pressure and malondialdehyde concentrations; however, there was no improvement in left ventricular hypertrophy, electrophysiology or vascular function. This study demonstrates the ability of epicatechin to reduce blood pressure, prevent myocardial stiffening and preserve cardiac compliance in hypertrophied DOCA-salt rat hearts. View Full-Text
Keywords: epicatechin; hypertension; DOCA-salt; electrophysiology; cardiac function epicatechin; hypertension; DOCA-salt; electrophysiology; cardiac function
Show Figures

Figure 1

MDPI and ACS Style

Jackson, D.; Connolly, K.; Batacan, R.; Ryan, K.; Vella, R.; Fenning, A. (−)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats. Molecules 2018, 23, 1511.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop